Usage: IBSRELA is indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
linzess
(linaclotide)
Allergan, Inc.
Usage: LINZESS is indicated for treating irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults, as well as functional constipation (FC) in pediatric patients aged 6 to 17 years.